国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2013年
8期
1135-1137
,共3页
兰索拉唑%达喜%胃溃疡
蘭索拉唑%達喜%胃潰瘍
란색랍서%체희%위궤양
Lansoprazole%Hydrotalcite%Gastric ulcer
目的 探讨兰索拉唑联用达喜(铝碳酸镁)治疗胃溃疡临床的疗效.方法 选自我院门诊198例胃溃疡的患者,分为治疗组105例,对照组93组,两组根除幽门螺杆菌(H.Pylori)三联治疗方法.1周后,治疗组用兰索拉唑和达喜治疗;对照只用兰索拉唑.1疗程为8周.结果 治疗组的痊愈率和总有效率分别为61.91％和93.33％;对照组的痊愈率和总有效率分别为40.09％和80.65％,两组的痊愈率和总有效率比较差异有统计学意义(P＜0.05).药物未见明显不良反应.结论 兰索拉唑联用达喜治疗胃溃疡,疗效较单用兰索拉唑显著.
目的 探討蘭索拉唑聯用達喜(鋁碳痠鎂)治療胃潰瘍臨床的療效.方法 選自我院門診198例胃潰瘍的患者,分為治療組105例,對照組93組,兩組根除幽門螺桿菌(H.Pylori)三聯治療方法.1週後,治療組用蘭索拉唑和達喜治療;對照隻用蘭索拉唑.1療程為8週.結果 治療組的痊愈率和總有效率分彆為61.91％和93.33％;對照組的痊愈率和總有效率分彆為40.09％和80.65％,兩組的痊愈率和總有效率比較差異有統計學意義(P＜0.05).藥物未見明顯不良反應.結論 蘭索拉唑聯用達喜治療胃潰瘍,療效較單用蘭索拉唑顯著.
목적 탐토란색랍서련용체희(려탄산미)치료위궤양림상적료효.방법 선자아원문진198례위궤양적환자,분위치료조105례,대조조93조,량조근제유문라간균(H.Pylori)삼련치료방법.1주후,치료조용란색랍서화체희치료;대조지용란색랍서.1료정위8주.결과 치료조적전유솔화총유효솔분별위61.91％화93.33％;대조조적전유솔화총유효솔분별위40.09％화80.65％,량조적전유솔화총유효솔비교차이유통계학의의(P＜0.05).약물미견명현불량반응.결론 란색랍서련용체희치료위궤양,료효교단용란색랍서현저.
Objective To investigate the clinical efficacy of treating gastric ulcer with hydrotalcite and lansoprazole.Methods 198 patients with gastric ulcer were randomly divided into treatment group (n=105)and control group (n=93).Two groups underwent firstly the eradication of helicobacter pylori and eradication triple therapy.From the second week,patients in the treatment group were treated with lansoprazole combined with hydrotalcite while patients in the control group were treated with lansoprazole only.The therapeutic course was 8 weeks.Results The cured rate and the total effective rate in treatment group were 61.91％ and 93.33％VS 33.33％ and 74.19％ in the control group.The differences were statistically significant between the two groups (P＜0.05).No obvious side effects occurred.Conclusion Treating gastric ulcer with lansoprazole and hydrotalcite has better effect than that with lansoprazole only.
